Whole-Food Plant-Based Diet (WFPBD) to Control Weight and Metabo-Inflammation inOverweight/Obese Men with Prostate Cancer Receiving Androgen Deprivation Therapy (ADT): A Multi-Center Randomized Control Trial
Study of Whole-Food Plant-Based Diet (WFPBD) to Control Weight in Overweight/Obese Men with Prostate Cancer
Sponsor: NA
Enrolling: Male Patients Only
IRB Number: AAAU4969
U.S. Govt. ID: NCT05471414
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: The purpose of this study is to assess the efficacy of a home-delivered whole-food plant-based diet (WFPBD) intervention in promoting weight loss in overweight or obese men with prostate cancer receiving androgen deprivation therapy (ADT), as compared to general nutritional counseling only. Another purpose is to assess how easy or difficult it is for patients to comply with a whole-foods plant-based diet, first when it is delivered to their home and later when they have to prepare it on their own. This trial will test whether an intervention such as a special diet is feasible, i.e., whether it is possible and practical for patients to follow the diet, and how the diet affects your weight, your percentage of body fat, and various laboratory tests that measure your risk for diabetes, cardiovascular disease, and other associated health problem.
Mark Stein, MD
Do You Qualify?
Are you 45 years or older? Yes No
Do you have a BMI (Body Mass Index) of 27 or over? Yes No
Have you been diagnosed with prostate cancer? Yes No
Has it been at least 3 months since completing chemotherapy and/or radiation? Yes No
Can you access emails? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Research Nurse Navigator